Publication Detail

Citation : Lin C, Grandinetti A, Shikuma C, Souza S, Parikh N, Nakamoto B, Kallianpur KJ, Chow D. (2013)
The effects of extended release niacin on lipoprotein sub-particle concentrations in HIV-infected patients.
Hawaii J Med Public Health 72(4):123-7.
Abstract : With the advent of highly active antiretroviral therapy (HAART), Cardiovascular Disease (CVD) has emerged as the leading cause of death in Human Immunodeficiency Virus (HIV) infected patients. An atherogenic lipoprotein phenotype has been described in HIV- infected patients with a predominance of small, low density lipoprotein (SLDL) particles with accompanying elevated triglycerides and reduced high density lipoprotein cholesterol. This randomized controlled pilot study was conducted to evaluate the efficacy of Extended Release Niacin (ERN) in improving the lipid profile in HIV patients. A total of 17 HIV positive subjects on HAART therapy with High Density Lipoprotein Cholesterol (HDL) levels below 40mg/dl and Low Density Lipoprotein Cholesterol (LDL) below 130mg/dl were enrolled. Nine were randomized to be treated with ERN titrated from a starting level of 500mg/night and titrated to a level of 1500mg/night. Eight patients were assigned to the control arm. No placebo was used. Lipoprotein profiles of the subjects were analyzed at baseline and at the end of 12 weeks using Nuclear Magnetic Resonance (NMR) spectroscopy. At the end of 12 weeks, NMR spectroscopic analysis revealed a significant increase in overall LDL size (1.2% in ERN treated subjects vs 2.0% decrease in control patients, P=.04) and a decrease in small LDL particle concentration (17.0% in ERN treated subjects vs 21.4% increase in control patients, P=.03) in subjects receiving ERN as compared to those in the control group. Only 1 subject receiving ERN developed serious flushing which was attributed to an accidental overdose of the drug. This pilot study demonstrates that ERN therapy in HIV-infected patients with low HDL is safe and effective in improving the lipoprotein profile in these patients.
URL Link :
PMID : 23795312
PMCID : PMC3689507
23 July 2018:
2018 Health Disparities Research Institute

Apply Now to the 2018 Health Disparities Research Institute!

The National Institute on Minority Health and Health Disparities (NIMHD) will host the…

12 July 2018:
Summer Career Development Workshop July 12-13, Seattle WA

Geographic Management of Cancer Health Disparities (GMap)
Summer Career Development Workshop July 12-13, Seattle WA

We want to hear from you! If h…

05 April 2018:
Meharry Medical College will host a Grant Writing Workshop on April 5-6, 2018

Meharry Translational Research Center (MeTRC), in conjunction with Office of Minority Health Resource Center (OMHRC), will host a Grant Writing Worksh…

View more news...

Seminars & Events
18 April 2018, 8am:
02 April 2018, 12pm - 2pm:
16 March 2018, 5pm:

View more seminars & events...

Supported by a grant from the National Institute on Minority Health and Health Disparities (U54MD007584), National Institutes of Health.